Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OBE001 for embryo implantation in IVF/ICSI
NCT02310802Phase 2Completed
- Sponsor
- ObsEva SA
- Start
- Nov 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of nolasiban in infertility (4 arms), sponsored by ObsEva SA. Primary endpoint: Percentage of women with an intra-uterine pregnancy with positive embryo heart-beat. Started Nov 2014; status: completed.
02
Drugs
nolasiban
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02310802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02310802.